4.6 Article

Daxx plays a novel role in T cell survival but is dispensable in Fas-induced apoptosis

期刊

PLOS ONE
卷 12, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0174011

关键词

-

资金

  1. NIH [R21 AI105794, R01 AI119069]
  2. NCI Cancer Center support grant [P30CA56036]

向作者/读者索取更多资源

Daxx was originally isolated as a Fas-binding protein. However, the in vivo function of Daxx in Fas-induced apoptosis has remained enigmatic. Fas plays an important role in homeostasis in the immune system. Fas gene mutations lead to autoimmune-lymphoproliferation (lpr) diseases characterized by hyperplasia of secondary lymphoid organs. It is well established that the FADD adaptor binds to Fas, and recruits/activates caspase 8. However, additional proteins including Daxx have also been indicated to associate with Fas. It was proposed that Daxx mediates a parallel apoptotic pathway that is independent of FADD and caspase 8, but signals through ASK1-mediated apoptotic pathway. However, because the deletion of Daxx leads to embryonic lethality, the in vivo function of Daxx has not been properly analyzed. In the current study, analysis was performed using a conditional mutant mouse in which Daxx was deleted specifically in T cells. The data show that Daxx(-/-) T cells were able to undergo normal Fas-induced apoptosis. While containing normal thymocyte populations, the T cell-specific Daxx(-/-) mice have a reduced peripheral T cell pool. Importantly, Daxx-deficient T cells displayed increased death responses upon activation through TCR stimulation. These results unequivocally demonstrated that Daxx does not mediate Fas-induced apoptosis, but rather that it plays a critical role in survival responses in primary mature T cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development

Xuhua Zhang, John P. Dowling, Jianke Zhang

CELL DEATH & DISEASE (2019)

Article Multidisciplinary Sciences

TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3

John P. Dowling, Mohamed Alsabbagh, Christina Del Casale, Zheng-Gang Liu, Jianke Zhang

NATURE COMMUNICATIONS (2019)

Article Immunology

Rabies-based vaccine induces potent immune responses against Nipah virus

Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

NPJ VACCINES (2019)

Article Immunology

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge

Drishya Kurup, Christine R. Fisher, Todd G. Smith, Tiago Abreu-Mota, Yong Yang, Felix R. Jackson, Nadia Gallardo-Romero, Richard Franka, Victor Bronshtein, Matthias J. Schnell

JOURNAL OF INFECTIOUS DISEASES (2019)

Article Immunology

Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2

Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell

NPJ VACCINES (2020)

Article Microbiology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model

Drishya Kurup, Delphine C. Malherbe, Christoph Wirblich, Rachael Lambert, Adam J. Ronk, Leila Zabihi Diba, Alexander Bukreyev, Matthias J. Schnell

Summary: The study developed an inactivated rabies virus vectored vaccine platform, resulting in a vaccine against SARS-CoV-2 named CORAVAX. CORAVAX demonstrated effectiveness in preventing viral replication and lung disease in hamster models, showing potential for robust immune responses in humans.

PLOS PATHOGENS (2021)

Article Immunology

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk, Chad Mire, Natalia Kuzmina, Noor Shaik, Sivakumar Periasamy, Matthew A. Hyde, Julie M. Williams, Pei-Yong Shi, Matthias J. Schnell, Alexander Bukreyev

Summary: The study developed a SARS-CoV-2 ConVac vaccine which, through animal experiments, showed that a single dose of the vaccine could rapidly control viral replication after disease challenge, protecting animals from weight loss and lung virus replication, with some inflammation still detected.

NPJ VACCINES (2021)

Article Immunology

Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein

Jillian M. DiMuzio, Baron C. Heimbach, Raymond J. Howanski, John P. Dowling, Nirja B. Patel, Noeleya Henriquez, Chris Nicolescu, Mitchell Nath, Antonio Polley, Jamie L. Bingaman, Todd Smith, Benjamin C. Harman, Matthew K. Robinson, Michael J. Morin, Pavel A. Nikitin

Summary: A study on the anti-viral memory B cell repertoire of convalescent patients showed that antibodies were produced against multiple viral proteins, with a majority targeting the Spike protein. This study suggests advantages of a function-based approach in identifying highly effective anti-viral antibodies against SARS-CoV-2.

VACCINE: X (2021)

Article Allergy

Current vaccine strategies against SARS-CoV-2: Promises and challenges

Drishya Kurup, Jacob Myers, Matthias J. Schnell

Summary: This review examines the path of vaccine discovery for COVID-19 and discusses challenges and opportunities. It also covers emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Virology

A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model

Drishya Kurup, Christoph Wirblich, Leila Zabihi Diba, Rachael Lambert, Megan Watson, Noor Shaikh, Holly Ramage, Charalambos Solomides, Matthias J. Schnell

Summary: This study reports the immunogenicity and efficacy of an adjuvanted single-dose vaccine called CORAVAX in hamsters. CORAVAX induces high levels of antibody immune response, preventing adverse reactions and diseases caused by virus infection. High levels of immune response to rabies were also observed.

VIRUSES-BASEL (2022)

Article Immunology

Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract

Drishya Kurup, Christoph Wirblich, Rachael Lambert, Leila Zabihi Diba, Benjamin E. Leiby, Matthias J. Schnell

Summary: The study showed that a measles vaccine expressing both ZIKV-E and -NS1 provided complete clearance of the virus and full protection for fetuses in a lethal Zika challenge model. NS1 antibodies were found to enhance the protective effects of ZIKV-E antibodies in the female reproductive tract.

NPJ VACCINES (2022)

Article Immunology

IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2

Pavel A. Nikitin, Jillian M. DiMuzio, John P. Dowling, Nirja B. Patel, Jamie L. Bingaman-Steele, Baron C. Heimbach, Noeleya Henriquez, Chris Nicolescu, Antonio Polley, Eden L. Sikorski, Raymond J. Howanski, Mitchell Nath, Halley Shukla, Suzanne M. Scheaffer, James P. Finn, Li-Fang Liang, Todd Smith, Nadia Storm, Lindsay G. A. McKay, Rebecca Johnson, Lauren E. Malsick, Anna N. Honko, Anthony Griffiths, Michael S. Diamond, Purnanand Sarma, Dennis H. Geising, Michael J. Morin, Matthew K. Robinson

Summary: Through the study of the B-cell repertoire of recovered COVID-19 patients, we identified human antibodies that can neutralize various variants of SARS-CoV-2. These antibodies form a cocktail that can effectively inhibit viral infection in vitro and in vivo, and induce antiviral responses in the body.

SCIENCE IMMUNOLOGY (2022)

Article Immunology

Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity

Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell

Summary: The objective of this study is to analyze the effectiveness of the recombinant rabies virus-vectored SARS-CoV-2 vaccine, CORAVAX, as a COVID-19 vaccine strategy. The study found that CORAVAX is immunogenic and protective against SARS-CoV-2, and it addresses the issue of waning immunity seen in other COVID-19 vaccines. By selecting the right adjuvants and tackling pre-existing rabies-vector immunity, CORAVAX has shown long-term potential as a COVID-19 vaccine.

NPJ VACCINES (2022)

Article Immunology

Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J. Schnell

Summary: Ebola virus is a major cause of severe hemorrhagic fever with a high mortality rate. An Ebola virus glycoprotein expressing inactivated bivalent filovirus/rabies virus vaccine called FILORAB1 has shown immunogenicity and protection against Ebola virus in mice and non-human primates, especially when formulated with toll-like receptor 4 agonist GLA and squalene oil-in-water emulsion. The immune response to FILORAB1 is long-lasting and characterized by maintained serum antibody titers and long-lived cells in the spleen and bone marrow.

NPJ VACCINES (2023)

Article Immunology

Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates

Drishya Kurup, Christine R. Fisher, Gabrielle Scher, Catherine Yankowski, AnnaMarie Testa, Rohan Keshwara, Tiago Abreu-Mota, Rachael Lambert, Melissa Ferguson, William Rinaldi, Leonard Ruiz, Christoph Wirblich, Matthias J. Schnell

Summary: The study evaluated the immunogenicity of adjuvanted monovalent rabies virus-based vaccine candidates against filoviruses and Lassa virus in nonhuman primates. Results showed strong and lasting immune responses up to 365 days, with no significant differences between single vaccines and trivalent or tetravalent vaccines. The study demonstrates the potential of a pentavalent vaccine platform against multiple viruses.

JOURNAL OF INFECTIOUS DISEASES (2021)

暂无数据